Status:
COMPLETED
Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization
Lead Sponsor:
University Health Network, Toronto
Conditions:
Uterine Leiomyomas
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Uterine artery embolization (UAE) is a minimally invasive treatment for women with symptomatic fibroids. It is similar to hysterectomy in term of satisfaction and symptoms improvement, with fewer comp...
Eligibility Criteria
Inclusion
- Indication for uterine fibroid embolization: bulk symptoms, pain or heavy menstrual bleeding attributed to fibroids, with imaging confirmation;
- Patient must be able to provide written, informed consent
Exclusion
- Documented of allergy or intolerance to lidocaine or other amide-type anesthetics;
- Personal or familial history of malignant familial hyperthermia;
- Documented history of second or third atrio-ventricular heart block
- Contra-indication to uterine fibroid embolization : active infection, suspected malignancy, coagulopathy, pregnancy or desire to preserve fertility, large pedunculated sub-serosal fibroid.
- History of previous uterine fibroid embolization.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02293447
Start Date
November 1 2014
End Date
March 1 2016
Last Update
May 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8